Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
  1. 3/A Insider 3/A
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale President, CNS Cancers US sold 13,609 shares at an average $75.55 ($1,028,165)
  4. 4 Open-market sale Chief Growth Officer sold 21,421 shares at $76.16 ($1,631,411)
  5. 4 Open-market sale Chief Operating Officer sold 25,635 shares at $76.16 ($1,952,346)
  6. 4 Open-market sale Chief Financial Officer sold 5,505 shares at $76.16 ($419,257)
  7. 4 Open-market sale Chief Human Resources Officer sold 593 shares at $76.16 ($45,163)
  8. 4 Grant or award Chief Innovation Officer acquired 32,766 shares (grant or award)
  9. 4 Open-market sale Chief Human Resources Officer sold 281 shares at $75.28 ($21,153)
  10. 4 Open-market sale Chief Growth Officer sold 937 shares at $75.28 ($70,535)
  11. 4 Open-market sale Chief Operating Officer sold 1,213 shares at $75.28 ($91,312)
  12. 4 Open-market sale Chief Financial Officer sold 1,055 shares at $75.28 ($79,418)
  13. 4 Open-market sale President, CNS Cancers US sold 2,903 shares at an average $76.95 ($223,393)
  14. 4 Open-market sale President, CNS Cancers US sold 4,107 shares at an average $75.38 ($309,578)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale President, CNS Cancers US sold 1,684 shares at $76.36 ($128,594)
  17. 4 Open-market sale Chief Growth Officer sold 1,923 shares at $76.36 ($146,845)
  18. 4 Grant or award Chief Innovation Officer acquired 12,992 shares (grant or award)
  19. 4 Grant or award General Counsel acquired 17,755 shares (grant or award)
  20. 4 Open-market sale Chief Financial Officer sold 2,198 shares at $76.36 ($167,845)

Page 9 of 39 · 780 filings